SC Tells Central Government to Make Sure That New Policy Will Not Raise Drug Prices
The Supreme Court of India has directed the central government to make sure that medicines will continue to be available at reasonable prices.
The Supreme Court of India has directed the central government to make sure that medicines will continue to be available at reasonable prices.
‘Ceiling prices of 31 scheduled formulation packs of intravenous fluids and 25 other formulations have been revised, along with eight formulations under the Drugs amendment order.’
Tweet it Now
Set up by the Union Ministry of Chemicals and Fertilizers, the authority fixes, revises and enforces prices of various controlled drugs. It also levies and collects penalties from manufacturers if customers are overcharged. It also monitors prices of decontrolled drugs to keep them affordable to the needy. The fresh order supersedes that of March 2, 2016, February 26, 2015 and December 10, 2014 on formulation packs. The ceiling prices are exclusive of local taxes where ever applicable.
Among the medicines whose prices have been revised include glucose and sodium chloride injections and their combined injections. The pharma firms whose drug prices have been revised lower are Abbot Healthcare, Adcock Ingram Healthcare, Alembic, Bennet Pharmaceuticals, Cadila Pharma, Cipla and others.
Canada Takes First Steps Toward Competitive Generic Drug Prices
An article published in CMAJ says that the commitment of Canadian premiers to lower generic drug prices is a major change in policy
An article published in CMAJ says that the commitment of Canadian premiers to lower generic drug prices is a major change in policy
Life-Saving Drug Prices To Rise Due To Withdrawal Of Customs Duty Exemption
The government withdrew customs duty exemption on import of 74 drugs including life-saving medicines used for treating cancer and HIV.
The government withdrew customs duty exemption on import of 74 drugs including life-saving medicines used for treating cancer and HIV.
Chinese Government To Lift Long-Standing State Controls On Drug Prices From June 1
Price controls will be relaxed over drugs covered by medical insurance, blood products, immunizations, anti-AIDS and birth-control medicines but not narcotics.
Price controls will be relaxed over drugs covered by medical insurance, blood products, immunizations, anti-AIDS and birth-control medicines but not narcotics.
